Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bifidobacterium breve strain Yakult fermented milk
- Development stage
- Unknown
- Lead developer
- Yakult Honsha
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Bifidobacterium breve strain Yakult fermented milk is a probiotic dairy product containing the proprietary B. breve strain Yakult, developed by Yakult Honsha. This live biotherapeutic product is designed to deliver viable B. breve bacteria to the intestines via oral consumption of a fermented milk matrix. The mechanism of action involves modulation of gut microbiota through colonization and production of lactic acid and acetic acid, which help stimulate intestinal activity, improve bowel movements, inhibit growth of harmful bacteria in the gut, and prevent intestinal putrefaction by suppressing production of harmful substances[4][6]. Clinical studies have also suggested benefits for immunity and skin health[5][6]. The primary indication is for general digestive health and maintenance or improvement of gut flora.
- Brand names
- Bifiene
- Other names
- Bifidobacterium breve strain Yakult fermented milkB. breve strain Yakult fermented milkBF-1 fermented milk drinkBF1 fermented milk drinkBF 1 fermented milk drink
Beyond the preview
Go deeper on Bifidobacterium breve strain Yakult fermented milk.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bifidobacterium breve strain Yakult fermented milk.